Announced positive preclinical results of GAI-122 injectable nanoemulsion.

On Wednesday, July 14, 2010, Dr. Joseph Schwarz, Chief Scientist of AlphaRx, will make an oral podium presentation of GAI-122 injectable nanoemulsion for neuroprotection. The total results conclude that, based on the neuroprotective properties of GAI-122 and the increased focus of GAI-122 in the mind after parenteral delivery in accordance with oral dosing, it is reasonable to expect an injectable type of GAI-122 predicated on a nanoemulsion, will provide the mandatory protection against damage to cognitive and behavioral features in humans experiencing numerous ischemic disorders.. AlphaRx reports positive preclinical outcomes of GAI-122 injectable nanoemulsion for Acute Ischemic Stroke AlphaRx, Inc.As of Thursday night, it remained unclear whether Reid’s maneuver would cost some GOP votes on either of the two expenses’ . CongressDaily: ‘Senate Minority Whip Kyl Thursday afternoon indicated Republicans would support the draft Finance bill, just as Reid was presenting small bill to Democrats. But Minority Head McConnell afterwards declined to endorse the Finance draft, calling it ‘a function in progress’ that’s ‘gonna end up being hashed out over the next couple of weeks’ .